1,296 results on '"Giudice M"'
Search Results
2. Current prospective management of patients with osteonecrosis drug-induced (bisphosphonates) of the jaws: our experience
- Author
-
Cristofaro M G and Giudice M
- Subjects
Geriatrics ,RC952-954.6 - Published
- 2010
- Full Text
- View/download PDF
3. Increasing lower incomes and reducing material deprivation: The beneficial role of social robots
- Author
-
Scuotto, V., Ballestra, L.V., Cuomo, M.T., and Del Giudice, M.
- Published
- 2024
- Full Text
- View/download PDF
4. Duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy in Ontario, Canada: a population-based cohort study
- Author
-
Ruco, Arlinda, Moineddin, Rahim, Sutradhar, Rinku, Tinmouth, Jill, Li, Qing, Rabeneck, Linda, Del Giudice, M Elisabetta, Dubé, Catherine, and Baxter, Nancy N
- Published
- 2024
- Full Text
- View/download PDF
5. Progress on probiotics as add-on therapy for allergic rhinitis
- Author
-
Ciprandi, G., Miraglia del Giudice, M., and Drago, L.
- Published
- 2024
- Full Text
- View/download PDF
6. An Enlarging Eczematous Patch of the Hip
- Author
-
May Lee, Marco, Satolli, Francesca, de Felici del Giudice, M. Beatrice, Norman, Robert A., Series Editor, Satolli, Francesca, editor, Tirant, Michael, editor, Wollina, Uwe, editor, and Lotti, Torello M., editor
- Published
- 2022
- Full Text
- View/download PDF
7. A Yellowish-Orange Nodule of the Chest
- Author
-
Massa, Alessandra, Zucchi, Alfredo, de Felici del Giudice, M. Beatrice, Norman, Robert A., Series Editor, Satolli, Francesca, editor, Tirant, Michael, editor, Wollina, Uwe, editor, and Lotti, Torello M., editor
- Published
- 2022
- Full Text
- View/download PDF
8. Daily versus every other day oral iron supplementation in patients with iron deficiency anemia (DEODO): study protocol for a phase 3 multicentered, pragmatic, open-label, pilot randomized controlled trial
- Author
-
Kron, Amie, Del Giudice, M. Elisabeth, Sholzberg, Michelle, Callum, Jeannie, Cserti-Gazdewich, Christine, Swarup, Vidushi, Huang, Mary, Distefano, Lanis, Anani, Waseem, Skeate, Robert, Armali, Chantal, and Lin, Yulia
- Published
- 2022
- Full Text
- View/download PDF
9. An Enlarging Eczematous Patch of the Hip
- Author
-
May Lee, Marco, primary, Satolli, Francesca, additional, and de Felici del Giudice, M. Beatrice, additional
- Published
- 2022
- Full Text
- View/download PDF
10. A Yellowish-Orange Nodule of the Chest
- Author
-
Massa, Alessandra, primary, Zucchi, Alfredo, additional, and de Felici del Giudice, M. Beatrice, additional
- Published
- 2022
- Full Text
- View/download PDF
11. A microfoundational perspective on SMEs’ growth in the digital transformation era
- Author
-
Scuotto, V, Nicotra, M., Del Giudice, M., Krueger, N., and Gregori, G.L.
- Published
- 2021
- Full Text
- View/download PDF
12. Adolescent gender dysphoria management: position paper from the Italian Academy of Pediatrics, the Italian Society of Pediatrics, the Italian Society for Pediatric Endocrinology and Diabetes, the Italian Society of Adolescent Medicine and the Italian Society of Child and Adolescent Neuropsychiatry
- Author
-
Calcaterra, V, Tornese, G, Zuccotti, G, Staiano, A, Cherubini, V, Gaudino, R, Fazzi, E, Barbi, E, Chiarelli, F, Corsello, G, Esposito, S, Ferrara, P, Iughetti, L, Laforgia, N, Maghnie, M, Marseglia, G, Perilongo, G, Pettoello-Mantovani, M, Ruggieri, M, Russo, G, Salerno, M, Striano, P, Valerio, G, Wasniewska, M, Agosti, M, Agostoni, C, Aiuti, A, Azzari, C, Badolato, R, Balduzzi, A, Baraldi, E, Canani, R, Biffi, A, Biondi, A, Bisogno, G, Pierri, N, Carnielli, V, Cianfarani, S, Cogo, P, Corvaglia, L, Dani, C, Di Salvo, G, Fagioli, F, Fanos, V, Ferrero, G, Francavilla, R, Galli, L, Gazzolo, D, Giaquinto, C, Giordano, P, Gitto, E, Grosso, S, Guarino, A, Indrio, F, Lanari, M, Lionetti, P, Locatelli, F, Lombardo, F, Maffeis, C, Marino, B, Midulla, F, Del Giudice, E, Del Giudice, M, Montini, G, Parenti, G, Parisi, P, Peroni, D, Perrotta, S, Piacentini, G, Pietrobelli, A, Raimondi, F, Ramenghi, U, Ravelli, A, Romano, C, Rossi, F, Rossi, P, Damiano, V, Spalice, A, Suppiej, A, Troncone, R, Verrotti, A, Null, N, Calcaterra, Valeria, Tornese, Gianluca, Zuccotti, Gianvincenzo, Staiano, Annamaria, Cherubini, Valentino, Gaudino, Rossella, Fazzi, Elisa Maria, Barbi, Egidio, Chiarelli, Francesco, Corsello, Giovanni, Esposito, Susanna Maria Roberta, Ferrara, Pietro, Iughetti, Lorenzo, Laforgia, Nicola, Maghnie, Mohamad, Marseglia, Gianluigi, Perilongo, Giorgio, Pettoello-Mantovani, Massimo, Ruggieri, Martino, Russo, Giovanna, Salerno, Mariacarolina, Striano, Pasquale, Valerio, Giuliana, Wasniewska, Malgorzata, Agosti, Massimo, Agostoni, Carlo Virginio, Aiuti, Alessandro, Azzari, Chiara, Badolato, Raffaele, Balduzzi, Adriana, Baraldi, Eugenio, Canani, Roberto Berni, Biffi, Alessandra, Biondi, Andrea, Bisogno, Gianni, Pierri, Nicola Brunetti, Carnielli, Virginio, Cianfarani, Stefano, Cogo, Paola, Corvaglia, Luigi, Dani, Carlo, Di Salvo, Giovanni, Fagioli, Franca, Fanos, Vassilios, Ferrero, Giovanni Battista, Francavilla, Ruggiero, Galli, Luisa, Gazzolo, Diego, Giaquinto, Carlo, Giordano, Paola, Gitto, Eloisa, Grosso, Salvatore, Guarino, Alfredo, Indrio, Flavia, Lanari, Marcello, Lionetti, Paolo, Locatelli, Franco, Lombardo, Fortunato, Maffeis, Claudio, Marino, Bruno, Midulla, Fabio, Del Giudice, Emanuele Miraglia, Del Giudice, Michele Miraglia, Montini, Giovanni, Parenti, Giancarlo, Parisi, Pasquale, Peroni, Diego, Perrotta, Silverio, Piacentini, Giorgio, Pietrobelli, Angelo, Raimondi, Francesco, Ramenghi, Ugo, Ravelli, Angelo, Romano, Claudio, Rossi, Francesca, Rossi, Paolo, Damiano, Vincenzo Salpietro, Spalice, Alberto, Suppiej, Agnese, Troncone, Riccardo, Verrotti, Alberto, null, null, Calcaterra, V, Tornese, G, Zuccotti, G, Staiano, A, Cherubini, V, Gaudino, R, Fazzi, E, Barbi, E, Chiarelli, F, Corsello, G, Esposito, S, Ferrara, P, Iughetti, L, Laforgia, N, Maghnie, M, Marseglia, G, Perilongo, G, Pettoello-Mantovani, M, Ruggieri, M, Russo, G, Salerno, M, Striano, P, Valerio, G, Wasniewska, M, Agosti, M, Agostoni, C, Aiuti, A, Azzari, C, Badolato, R, Balduzzi, A, Baraldi, E, Canani, R, Biffi, A, Biondi, A, Bisogno, G, Pierri, N, Carnielli, V, Cianfarani, S, Cogo, P, Corvaglia, L, Dani, C, Di Salvo, G, Fagioli, F, Fanos, V, Ferrero, G, Francavilla, R, Galli, L, Gazzolo, D, Giaquinto, C, Giordano, P, Gitto, E, Grosso, S, Guarino, A, Indrio, F, Lanari, M, Lionetti, P, Locatelli, F, Lombardo, F, Maffeis, C, Marino, B, Midulla, F, Del Giudice, E, Del Giudice, M, Montini, G, Parenti, G, Parisi, P, Peroni, D, Perrotta, S, Piacentini, G, Pietrobelli, A, Raimondi, F, Ramenghi, U, Ravelli, A, Romano, C, Rossi, F, Rossi, P, Damiano, V, Spalice, A, Suppiej, A, Troncone, R, Verrotti, A, Null, N, Calcaterra, Valeria, Tornese, Gianluca, Zuccotti, Gianvincenzo, Staiano, Annamaria, Cherubini, Valentino, Gaudino, Rossella, Fazzi, Elisa Maria, Barbi, Egidio, Chiarelli, Francesco, Corsello, Giovanni, Esposito, Susanna Maria Roberta, Ferrara, Pietro, Iughetti, Lorenzo, Laforgia, Nicola, Maghnie, Mohamad, Marseglia, Gianluigi, Perilongo, Giorgio, Pettoello-Mantovani, Massimo, Ruggieri, Martino, Russo, Giovanna, Salerno, Mariacarolina, Striano, Pasquale, Valerio, Giuliana, Wasniewska, Malgorzata, Agosti, Massimo, Agostoni, Carlo Virginio, Aiuti, Alessandro, Azzari, Chiara, Badolato, Raffaele, Balduzzi, Adriana, Baraldi, Eugenio, Canani, Roberto Berni, Biffi, Alessandra, Biondi, Andrea, Bisogno, Gianni, Pierri, Nicola Brunetti, Carnielli, Virginio, Cianfarani, Stefano, Cogo, Paola, Corvaglia, Luigi, Dani, Carlo, Di Salvo, Giovanni, Fagioli, Franca, Fanos, Vassilios, Ferrero, Giovanni Battista, Francavilla, Ruggiero, Galli, Luisa, Gazzolo, Diego, Giaquinto, Carlo, Giordano, Paola, Gitto, Eloisa, Grosso, Salvatore, Guarino, Alfredo, Indrio, Flavia, Lanari, Marcello, Lionetti, Paolo, Locatelli, Franco, Lombardo, Fortunato, Maffeis, Claudio, Marino, Bruno, Midulla, Fabio, Del Giudice, Emanuele Miraglia, Del Giudice, Michele Miraglia, Montini, Giovanni, Parenti, Giancarlo, Parisi, Pasquale, Peroni, Diego, Perrotta, Silverio, Piacentini, Giorgio, Pietrobelli, Angelo, Raimondi, Francesco, Ramenghi, Ugo, Ravelli, Angelo, Romano, Claudio, Rossi, Francesca, Rossi, Paolo, Damiano, Vincenzo Salpietro, Spalice, Alberto, Suppiej, Agnese, Troncone, Riccardo, Verrotti, Alberto, and null, null
- Abstract
Background In response to the imperative need for standardized support for adolescent Gender Dysphoria (GD), the Italian Academy of Pediatrics, in collaboration with the Italian Society of Pediatrics, the Italian Society for Pediatric Endocrinology and Diabetes, Italian Society of Adolescent Medicine and Italian Society of Child and Adolescent Neuropsychiatry is drafting a position paper. The purpose of this paper is to convey the author's opinion on the topic, offering foundational information on potential aspects of gender-affirming care and emphasizing the care and protection of children and adolescents with GD.Main body Recognizing that adolescents may choose interventions based on their unique needs and goals and understanding that every individual within this group has a distinct trajectory, it is crucial to ensure that each one is welcomed and supported. The approach to managing individuals with GD is a multi-stage process involving a multidisciplinary team throughout all phases. Decisions regarding treatment should be reached collaboratively by healthcare professionals and the family, while considering the unique needs and circumstances of the individual and be guided by scientific evidence rather than biases or ideologies. Politicians and high court judges should address discrimination based on gender identity in legislation and support service development that aligns with the needs of young people. It is essential to establish accredited multidisciplinary centers equipped with the requisite skills and experience to effectively manage adolescents with GD, thereby ensuring the delivery of high-quality care.Conclusion Maintaining an evidence-based approach is essential to safeguard the well-being of transgender and gender diverse adolescents.
- Published
- 2024
13. Imaging in gynecological disease (27): clinical and ultrasound characteristics of recurrent ovarian stromal cell tumors
- Author
-
Moro, Francesca, Giudice, M. T., Bolomini, G., Moruzzi, M. C., Mascilini, F., Quagliozzi, L., Ciccarone, F., Scambia, Giovanni, Fagotti, Anna, Valentin, L., Testa, Antonia Carla, Moro, F., Scambia, G. (ORCID:0000-0003-2758-1063), Fagotti, A. (ORCID:0000-0001-5579-335X), Testa, A. C. (ORCID:0000-0003-2217-8726), Moro, Francesca, Giudice, M. T., Bolomini, G., Moruzzi, M. C., Mascilini, F., Quagliozzi, L., Ciccarone, F., Scambia, Giovanni, Fagotti, Anna, Valentin, L., Testa, Antonia Carla, Moro, F., Scambia, G. (ORCID:0000-0003-2758-1063), Fagotti, A. (ORCID:0000-0001-5579-335X), and Testa, A. C. (ORCID:0000-0003-2217-8726)
- Abstract
Objective To describe the clinical and ultrasound characteristics of recurrent granulosa cell and Sertoli-Leydig cell tumors. Methods This was a retrospective observational study performed at Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS, Rome (Gemelli center). Patients with a histological diagnosis of recurrent granulosa cell tumor or Sertoli-Leydig cell tumor were identified from the database of the Department of Gynecological Oncology. Those who had undergone a preoperative ultrasound examination at the Gemelli center between 2012 and 2020 were included, and the data retrieved from the original ultrasound reports. In all of these reports, the recurrent tumors were described using International Ovarian Tumor Analysis (IOTA) terminology. If a patient had more than one episode of relapse, information from all episodes was collected. If there was more than one recurrent tumor at the same ultrasound examination, all tumors were included. One expert sonographer also reviewed all available ultrasound images to identify typical ultrasound patterns using pattern recognition. Results We identified 30 patients with a histological diagnosis of recurrent granulosa cell tumor (25 patients, 55 tumors) or Sertoli-Leydig cell tumor (five patients, seven tumors). All 30 had undergone at least one preoperative ultrasound examination at the Gemelli center and were included. These women had a total of 66 episodes of relapse, of which a preoperative ultrasound examination had been performed at the Gemelli center in 34, revealing 62 recurrent lesions: one in 22/34 (64.7%) episodes of relapse, two in 4/34 (11.8%) episodes and three or more in 8/34 (23.5%) episodes. Most recurrent granulosa cell tumors (38/55, 69.1%) and recurrent Sertoli-Leydig tumors (6/7, 85.7%) were classified as solid or multilocular-solid tumors, while 8/55 (14.5%) recurrent granulosa cell tumors and 1/7 (14.3%) recurrent Sertoli-Leydig cell tumors were
- Published
- 2024
14. Antihistamines in children and adolescents: A practical update
- Author
-
Parisi, G.F., Leonardi, S., Ciprandi, G., Corsico, A., Licari, A., Miraglia del Giudice, M., Peroni, D., Salpietro, C., and Marseglia, G.L.
- Published
- 2020
- Full Text
- View/download PDF
15. BIM model uses through BIM methodology standardization
- Author
-
Barbero, A., primary, Del Giudice, M., additional, Ugliotti, F.M., additional, and Osello, A., additional
- Published
- 2021
- Full Text
- View/download PDF
16. A BIM to BEM approach for data exchange: advantages and weaknesses for industrial buildings energy assessment
- Author
-
Del Giudice, M., primary, Dettori, M., additional, Magnano, S., additional, and Osello, A., additional
- Published
- 2021
- Full Text
- View/download PDF
17. Shifting Wealth II in Chinese economy. The effect of the horizontal technology spillover for SMEs for international growth
- Author
-
Del Giudice, M., Scuotto, V., Garcia-Perez, A., and Messeni Petruzzelli, A.
- Published
- 2019
- Full Text
- View/download PDF
18. Vitamin D and asthma in children: insights from total and free 25-hydroxyvitamin D and vitamin D binding protein measurements
- Author
-
Allegorico, A., primary, Ruggiero, L., additional, Capristo, C., additional, Parisi, G., additional, Indolfi, C., additional, Umano, G.R., additional, Vuilleumier, P., additional, Dinardo, G., additional, and Miraglia del Giudice, M., additional
- Published
- 2023
- Full Text
- View/download PDF
19. OC12.02: Clinical and ultrasound characteristics of granulosa cell and Sertoli Leydig cell tumour recurrences
- Author
-
Moro, F., primary, Giudice, M., additional, Bolomini, G., additional, Moruzzi, M., additional, Mascilini, F., additional, Quagliozzi, L., additional, Ciccarone, F., additional, Pozzati, F., additional, Valentin, L., additional, and Testa, A. C., additional
- Published
- 2023
- Full Text
- View/download PDF
20. OP09.03: Tailgut cyst mistaken for pelvic endometriotic nodule: a case report
- Author
-
Quagliozzi, L., primary, Robba, E., additional, Sassu, C., additional, Giudice, M., additional, Moro, F., additional, Ciccarone, F., additional, Mascilini, F., additional, Pozzati, F., additional, Scambia, G., additional, Ianieri, M., additional, and Testa, A. C., additional
- Published
- 2023
- Full Text
- View/download PDF
21. The moduli space of \'etale double covers of genus 5 curves is unirational
- Author
-
Izadi, E., Giudice, M. Lo, and Sankaran, G. K.
- Subjects
Mathematics - Algebraic Geometry ,14H15, 14H40, 14K10 - Abstract
We show that the coarse moduli space $\cR_5$ of \'etale double covers of curves of genus~5 over the complex numbers is unirational. We give two slightly different arguments, one purely geometric and the other more computational., Comment: 14 pages
- Published
- 2008
22. Role of the geriatrician, primary care practitioner, nurses, and collaboration with oncologists during cancer treatment delivery for older adults: A narrative review of the literature
- Author
-
Puts, Martine T.E., Strohschein, Fay J., Del Giudice, M. Elisabeth, Jin, Rana, Loucks, Allison, Ayala, Ana Patricia, and Alibhai, Shabbir H.M.
- Published
- 2018
- Full Text
- View/download PDF
23. Imaging in gynecological disease: clinical and ultrasound characteristics of recurrent ovarian stromal cell tumors
- Author
-
Moro, F., primary, Giudice, M. T., additional, Bolomini, G., additional, Moruzzi, M. C., additional, Mascilini, F., additional, Quagliozzi, L., additional, Ciccarone, F., additional, Scambia, G., additional, Fagotti, A., additional, Valentin, L., additional, and Testa, A. C., additional
- Published
- 2023
- Full Text
- View/download PDF
24. The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysis
- Author
-
Zeitouny, Seraphine, primary, Cheung, Douglas C., additional, Bremner, Karen E., additional, Pataky, Reka E., additional, Pequeno, Priscila, additional, Matelski, John, additional, Peacock, Stuart, additional, Del Giudice, M. Elisabeth, additional, Lapointe-Shaw, Lauren, additional, Tomlinson, George, additional, Mendlowitz, Andrew B., additional, Mulder, Carol, additional, Tsui, Teresa C. O., additional, Perlis, Nathan, additional, Walker, Jennifer D., additional, Sander, Beate, additional, Wong, William W. L., additional, Krahn, Murray D., additional, and Kulkarni, Girish S., additional
- Published
- 2023
- Full Text
- View/download PDF
25. Do circular economy practices affect corporate performance? Evidence from <scp>Italian</scp> large‐sized manufacturing firms
- Author
-
Mazzucchelli A., Chierici R., Del Giudice M., Bua I., Mazzucchelli, A, Chierici, R, Del Giudice, M, and Bua, I
- Subjects
corporate social responsibility ,Strategy and Management ,circular economy ,brand reputation ,Management, Monitoring, Policy and Law ,Development ,firm performance - Abstract
In recent years, corporate social responsibility has become the most outstanding challenges for firms and circular economy has emerged as an innovative business model able to transform corporate social responsibility into actions. Even if by adopting such a strategic model firms could enhance their performance, results continue to be mixed and unclear. The aim of the paper is twofold. First, the study investigates the effect of three circular economy practices (waste treatment, reduction and recycling), on brand reputation and financial performance. Second, the study tests the role of brand reputation in mediating the relationship between circular economy practices and financial performance. The findings highlight the crucial role of 3Rs practices and of brand reputation in enhancing firm performance. This paper contributes to a better understanding on the relationship between circular economy practices, as sustainable strategic and managerial practices, and firm performance, in both marketing and financial terms. Moreover, it sheds light on circular economy implementation and its effect at the firm level, by analyzing managers perceptions on how firms and policy makers have to incorporate the circular economy concept in their sustainability agenda.
- Published
- 2022
- Full Text
- View/download PDF
26. Imaging in gynecological disease (27): clinical and ultrasound characteristics of recurrent ovarian stromal cell tumors.
- Author
-
Moro, F., Giudice, M. T., Bolomini, G., Moruzzi, M. C., Mascilini, F., Quagliozzi, L., Ciccarone, F., Scambia, G., Fagotti, A., Valentin, L., and Testa, A. C.
- Subjects
- *
CELL tumors , *FEMALE reproductive organ diseases , *STROMAL cells , *ULTRASONIC imaging , *GRANULOSA cell tumors , *OVARIAN tumors - Abstract
Objective: To describe the clinical and ultrasound characteristics of recurrent granulosa cell and Sertoli–Leydig cell tumors. Methods: This was a retrospective observational study performed at Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS, Rome (Gemelli center), Italy. Patients with a histological diagnosis of recurrent granulosa cell tumor or Sertoli–Leydig cell tumor were identified from the database of the Department of Gynecological Oncology. Those who had undergone a preoperative ultrasound examination at the Gemelli center between 2012 and 2020 were included, and the data retrieved from the original ultrasound reports. In all of these reports, the recurrent tumors were described using International Ovarian Tumor Analysis (IOTA) terminology. If a patient had more than one episode of relapse, information from all episodes was collected. If there was more than one recurrent tumor at the same ultrasound examination, all tumors were included. One expert sonographer also reviewed all available ultrasound images to identify typical ultrasound patterns using pattern recognition. Results: We identified 30 patients with a histological diagnosis of recurrent granulosa cell tumor (25 patients, 55 tumors) or Sertoli–Leydig cell tumor (five patients, seven tumors). All 30 had undergone at least one preoperative ultrasound examination at the Gemelli center and were included. These women had a total of 66 episodes of relapse, of which a preoperative ultrasound examination had been performed at the Gemelli center in 34, revealing 62 recurrent lesions: one in 22/34 (64.7%) episodes of relapse, two in 4/34 (11.8%) episodes and three or more in 8/34 (23.5%) episodes. Most recurrent granulosa cell tumors (38/55, 69.1%) and recurrent Sertoli–Leydig tumors (6/7, 85.7%) were classified as solid or multilocular‐solid tumors, while 8/55 (14.5%) recurrent granulosa cell tumors and 1/7 (14.3%) recurrent Sertoli–Leydig cell tumors were unilocular cysts and 9/55 (16.4%) recurrent granulosa cell tumors were multilocular cysts. The nine unilocular cysts had contents that were anechoic (n = 2) or had low‐level echogenicity (n = 7), had either smooth (n = 4) or irregular (n = 5) internal cyst walls, and ranged in largest diameter from 8 to 38 mm, with three being < 20 mm and five being 20–30 mm. On retrospective review of the images, two typical ultrasound patterns were described: small solid tumor measuring < 2 cm (15/62, 24.2%) and tumor with vascularized echogenic ground‐glass‐like content (12/62, 19.4%). Conclusions: Some granulosa cell and Sertoli–Leydig cell recurrences manifest one of two typical ultrasound patterns, while some appear as unilocular cysts. These are usually classified as benign, but in patients being followed up for a granulosa cell tumor or Sertoli–Leydig cell tumor, a unilocular cyst should be considered suspicious of recurrence. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Do circular economy practices affect corporate performance? Evidence from Italian large-sized manufacturing firms
- Author
-
Mazzucchelli, A, Chierici, R, Del Giudice, M, Bua, I, Mazzucchelli A., Chierici R., Del Giudice M., Bua I., Mazzucchelli, A, Chierici, R, Del Giudice, M, Bua, I, Mazzucchelli A., Chierici R., Del Giudice M., and Bua I.
- Abstract
In recent years, corporate social responsibility has become the most outstanding challenges for firms and circular economy has emerged as an innovative business model able to transform corporate social responsibility into actions. Even if by adopting such a strategic model firms could enhance their performance, results continue to be mixed and unclear. The aim of the paper is twofold. First, the study investigates the effect of three circular economy practices (waste treatment, reduction and recycling), on brand reputation and financial performance. Second, the study tests the role of brand reputation in mediating the relationship between circular economy practices and financial performance. The findings highlight the crucial role of 3Rs practices and of brand reputation in enhancing firm performance. This paper contributes to a better understanding on the relationship between circular economy practices, as sustainable strategic and managerial practices, and firm performance, in both marketing and financial terms. Moreover, it sheds light on circular economy implementation and its effect at the firm level, by analyzing managers perceptions on how firms and policy makers have to incorporate the circular economy concept in their sustainability agenda.
- Published
- 2022
28. FROM AN INTEGRATED SURVEY WITH MMS TO A SCAN-TO-BIM PROCESS FOR EDUCATIONAL PURPOSES
- Author
-
Matrone, F., primary, Colucci, E., additional, Ugliotti, F. M., additional, and Del Giudice, M., additional
- Published
- 2023
- Full Text
- View/download PDF
29. Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer
- Author
-
Conte, Carmine, Marchetti, Claudia, Loverro, Matteo, Giudice, M. T., Rosati, A., Gallotta, Valerio, Scambia, Giovanni, Fagotti, Anna, Conte C., Marchetti C. (ORCID:0000-0001-7098-8956), Loverro M., Gallotta V., Scambia G. (ORCID:0000-0003-2758-1063), Fagotti A. (ORCID:0000-0001-5579-335X), Conte, Carmine, Marchetti, Claudia, Loverro, Matteo, Giudice, M. T., Rosati, A., Gallotta, Valerio, Scambia, Giovanni, Fagotti, Anna, Conte C., Marchetti C. (ORCID:0000-0001-7098-8956), Loverro M., Gallotta V., Scambia G. (ORCID:0000-0003-2758-1063), and Fagotti A. (ORCID:0000-0001-5579-335X)
- Abstract
Objective Retrospective series have shown minimally invasive secondary cytoreductive surgery is a feasible approach in selected cases of recurrent ovarian cancer. However, no predictors of minimally invasive secondary cytoreductive surgery feasibility are currently available. This study aims to identify predictive factors of minimally invasive secondary cytoreductive surgery feasibility and to compare perioperative and survival outcomes in a matched series of recurrent ovarian cancer patients who underwent secondary cytoreduction via an open or minimally invasive surgical approach. Methods We retrospectively identified all platinum-sensitive recurrent epithelial ovarian cancer patients who underwent minimally invasive or laparotomic secondary cytoreductive surgery between January 2013 and July 2020. Each patient underwent a preoperative positron emission tomography (PET) computerized tomography (CT) scan and diagnostic laparoscopy before secondary cytoreductive surgery. A 1:2 propensity score-matched analysis was performed to balance predictive factors of minimally invasive secondary cytoreductive surgery. Results Overall, 276 patients were identified (62 minimally invasive and 214 open), and a complete gross resection was achieved in 262 (94.9%) patients. At multivariate analysis, predictive factors for minimally invasive secondary cytoreductive surgery were neoadjuvant chemotherapy at first diagnosis (p=0.007), site of recurrence (p=0.031), and number of lesions (p=0.001). In the 1:2 propensity-matched population (39 minimally invasive and 78 open), complete gross resection was similar for both groups (p=0.082). Early post-operative complications were significantly higher in the laparotomy (33.3%) than in the minimally invasive surgery (10.3%) group (p=0.004). Only one (2.6%) patient experienced a grade >3 early post-operative complication in the minimally invasive surgery group compared with 13 (16.7%) patients in the open cohort (p<0.001). The median follo
- Published
- 2023
30. A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis
- Author
-
Stingeni, L., Bianchi, L., Antonelli, E., Caroppo, E. S., Ferrucci, S. M., Gurioli, C., Ortoncelli, M., Fabbrocini, G., Nettis, E., Schena, D., Napolitano, M., Gola, M., Bonzano, L., Rossi, M., Belloni Fortina, A., Balato, A., Peris, Ketty, Foti, C., Guarneri, F., Romanelli, M., Patruno, C., Savoia, P., Esposito, M., Russo, F., Errichetti, E., Bianchelli, T., Pellacani, G., Feliciani, C., Offidani, A., Corazza, M., Micali, G., Milanesi, N., Malara, G., Chiricozzi, Andrea, Tramontana, M., Hansel, K., Buligan, C., Caroppo, F., Bello, G. D., Dastoli, S., Di Brizzi, E. V., Del Giudice, M. B. D. F., Diluvio, L., Fargnoli, Maria Concetta, Gelmetti, A., Giacchetti, A., Grieco, T., Iannone, M., Macchia, L., Marietti, R., Musumeci, M. L., Motolese, A., Neri, I., Radi, G., Ribero, S., Romita, P., Tavecchio, S., Tronconi, G., Veronese, F., Peris K. (ORCID:0000-0002-5237-0463), Chiricozzi A. (ORCID:0000-0002-6739-0387), Fargnoli M. C., Stingeni, L., Bianchi, L., Antonelli, E., Caroppo, E. S., Ferrucci, S. M., Gurioli, C., Ortoncelli, M., Fabbrocini, G., Nettis, E., Schena, D., Napolitano, M., Gola, M., Bonzano, L., Rossi, M., Belloni Fortina, A., Balato, A., Peris, Ketty, Foti, C., Guarneri, F., Romanelli, M., Patruno, C., Savoia, P., Esposito, M., Russo, F., Errichetti, E., Bianchelli, T., Pellacani, G., Feliciani, C., Offidani, A., Corazza, M., Micali, G., Milanesi, N., Malara, G., Chiricozzi, Andrea, Tramontana, M., Hansel, K., Buligan, C., Caroppo, F., Bello, G. D., Dastoli, S., Di Brizzi, E. V., Del Giudice, M. B. D. F., Diluvio, L., Fargnoli, Maria Concetta, Gelmetti, A., Giacchetti, A., Grieco, T., Iannone, M., Macchia, L., Marietti, R., Musumeci, M. L., Motolese, A., Neri, I., Radi, G., Ribero, S., Romita, P., Tavecchio, S., Tronconi, G., Veronese, F., Peris K. (ORCID:0000-0002-5237-0463), Chiricozzi A. (ORCID:0000-0002-6739-0387), and Fargnoli M. C.
- Abstract
na
- Published
- 2023
31. The Nexus Between Big Data Analytics and the Proliferation of Fake News as a Precursor to Online and Offline Criminal Activities
- Author
-
Evangelatos, S., Papadakis, T., Gousetis, N., Nikolopoulos, C., Troulitaki, P., Dimakopoulos, N., Bravos, G., Giudice, M. V. L., Yazdi, A. S., Aziani, Alberto, Aziani A. (ORCID:0000-0002-4745-7337), Evangelatos, S., Papadakis, T., Gousetis, N., Nikolopoulos, C., Troulitaki, P., Dimakopoulos, N., Bravos, G., Giudice, M. V. L., Yazdi, A. S., Aziani, Alberto, and Aziani A. (ORCID:0000-0002-4745-7337)
- Abstract
This paper presents a novel framework for the thorough analysis of fake news and disinformation campaigns, which have the potential to result in both offline and online criminal activities. Its primary focus relies on the spread analysis of disinformation across social media and online platforms, aiming to uncover the underlying dynamics and mechanisms driving the dissemination of false information. The framework integrates state-of-the-art Natural Language Processing (NLP) techniques for sentiment analysis, Deep Learning (DL) algorithms for prediction of criminal activties related to the disiformation spread and graph analysis to identify key actors and propagation pathways. To address the emerging challenges of disinformation that transcend the online realm and have tangible real-world consequences, the framework extends its analysis to potential offline actions incited by disinformation, such as acts of violence and public unrest or the disruption of public health efforts especially in case of pandemics. By exploring the complex interconnections between disinformation and crimes, our research aims to contribute to a deeper understanding of the societal implications of false information and provide actionable insights for policymakers, security practitioners and the broader public.
- Published
- 2023
32. Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity
- Author
-
Petrone, V, Fanelli, M, Giudice, M, Toschi, N, Conti, A, Maracchioni, C, Iannetta, M, Resta, C, Cipriani, C, Miele, Mt, Amati, F, Andreoni, M, Sarmati, L, Rogliani, P, Novelli, G, Garaci, E, Rasi, G, Sinibaldi-Vallebona, P, Minutolo, A, Matteucci, C, Balestrieri, E, and Grelli, S
- Subjects
Microbiology (medical) ,Microbiology ,Settore MED/07 - Abstract
IntroductionOur research group and others demonstrated the implication of the human endogenous retroviruses (HERVs) in SARS-CoV-2 infection and their association with disease progression, suggesting HERVs as contributing factors in COVID-19 immunopathology. To identify early predictive biomarkers of the COVID-19 severity, we analyzed the expression of HERVs and inflammatory mediators in SARS-CoV-2-positive and -negative nasopharyngeal/oropharyngeal swabs with respect to biochemical parameters and clinical outcome.MethodsResiduals of swab samples (20 SARS-CoV-2-negative and 43 SARS-CoV-2-positive) were collected during the first wave of the pandemic and expression levels of HERVs and inflammatory mediators were analyzed by qRT-Real time PCR.ResultsThe results obtained show that infection with SARS-CoV-2 resulted in a general increase in the expression of HERVs and mediators of the immune response. In particular, SARS-CoV-2 infection is associated with increased expression of HERV-K and HERV-W, IL-1β, IL-6, IL-17, TNF-α, MCP-1, INF-γ, TLR-3, and TLR-7, while lower levels of IL-10, IFN-α, IFN-β, and TLR-4 were found in individuals who underwent hospitalization. Moreover, higher expression of HERV-W, IL-1β, IL-6, IFN-α, and IFN-β reflected the respiratory outcome of patients during hospitalization. Interestingly, a machine learning model was able to classify hospitalized vs not hospitalized patients with good accuracy based on the expression levels of HERV-K, HERV-W, IL-6, TNF-a, TLR-3, TLR-7, and the N gene of SARS-CoV-2. These latest biomarkers also correlated with parameters of coagulation and inflammation.DiscussionOverall, the present results suggest HERVs as contributing elements in COVID-19 and early genomic biomarkers to predict COVID-19 severity and disease outcome.
- Published
- 2023
- Full Text
- View/download PDF
33. Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement
- Author
-
Lanari, M., Venturini, E., Pierantoni, L., Stera, G., Castelli Gattinara, G., Esposito, S. M. R., Favilli, S., Franzoni, E., Fusco, E., Lionetti, P., Maffeis, C., Marseglia, G., Massella, L., Midulla, F., Zanobini, A., Zecca, M., Villani, A., Staiano, A., Galli, L., Blasi, F., Di Giorgio, A., Dona, D., Licari, A., Martinelli, M., Mastrangelo, A., Miraglia del Giudice, M., Nicolini, G., Pugliese, F., Striano, P., Valerio, G., Lanari, M., Venturini, E., Pierantoni, L., Stera, G., Castelli Gattinara, G., Esposito, S. M. R., Favilli, S., Franzoni, E., Fusco, E., Lionetti, P., Maffeis, C., Marseglia, G., Massella, L., Midulla, F., Zanobini, A., Zecca, M., Villani, A., Staiano, A., Galli, L., Blasi, F., Di Giorgio, A., Dona, D., Licari, A., Martinelli, M., Mastrangelo, A., Miraglia del Giudice, M., Nicolini, G., Pugliese, F., Striano, P., Valerio, G., Lanari M., Venturini E., Pierantoni L., Stera G., Castelli Gattinara G., Esposito S.M.R., Favilli S., Franzoni E., Fusco E., Lionetti P., Maffeis C., Marseglia G., Massella L., Midulla F., Zanobini A., Zecca M., Villani A., Staiano A., Galli L., Blasi F., Di Giorgio A., Dona D., Licari A., Martinelli M., Mastrangelo A., Miraglia del Giudice M., Nicolini G., Pugliese F., Striano P., Valerio G., Lanari, M, Venturini, E, Pierantoni, L, Castelli Gattinara, G. Esposito S. M. R., Favilli, S, Franzoni, E, Marseglia, G, Massella, L, Zecca, M, Villani, A, Staiano, A, Galli, L, Blasi, F, and Donà, D.
- Subjects
Monoclonal antibody ,Consensus ,Adolescent ,COVID19 ,Consensu ,Review ,Antibodies, Monoclonal, Humanized ,Adolescents ,Pediatrics ,Antiviral Agents ,RJ1-570 ,Drug Combination ,Humans ,Age Factor ,Child ,Societies, Medical ,Antiviral Agent ,Risk Factor ,Patient Selection ,Age Factors ,Antibodies, Monoclonal ,COVID-19 ,Settore MED/38 ,Antibodies, Neutralizing ,COVID-19 Drug Treatment ,Drug Combinations ,Italy ,Risk factors ,Risk Factors ,Human - Abstract
The fast diffusion of the SARS-CoV-2 pandemic have called for an equally rapid evolution of the therapeutic options.The Human recombinant monoclonal antibodies (mAbs) have recently been approved by the Food and Drug Administration (FDA) and by the Italian Medicines Agency (AIFA) in subjects aged ≥12 with SARS-CoV-2 infection and specific risk factors.Currently the indications are specific for the use of two different mAbs combination: Bamlanivimab+Etesevimab (produced by Eli Lilly) and Casirivimab+Imdevimab (produced by Regeneron).These drugs have shown favorable effects in adult patients in the initial phase of infection, whereas to date few data are available on their use in children.AIFA criteria derived from the existing literature which reports an increased risk of severe COVID-19 in children with comorbidities. However, the studies analyzing the determinants for progression to severe disease are mainly monocentric, with limited numbers and reporting mostly generic risk categories.Thus, the Italian Society of Pediatrics invited its affiliated Scientific Societies to produce a Consensus document based on the revision of the criteria proposed by AIFA in light of the most recent literature and experts’ agreement.This Consensus tries to detail which patients actually have the risk to develop severe disease, analyzing the most common comorbidities in children, in order to detail the indications for mAbs administration and to guide the clinicians in identifying eligible patients.
- Published
- 2022
34. BIM model methods for suppliers in the building process
- Author
-
Barbero, A., primary, Del Giudice, M., additional, and Manzone, F., additional
- Published
- 2018
- Full Text
- View/download PDF
35. Hexavalent vaccines in preterm infants: an update by Italian Society of Pediatric Allergy and Immunology jointly with the Italian Society of Neonatology
- Author
-
Chiappini, E., Petrolini, C., Caffarelli, C., Calvani, M., Cardinale, F., Duse, M., Licari, A., Manti, S., Martelli, A., Minasi, D., Miraglia Del Giudice, M., Pajno, GB., Pietrasanta, C., Pugni, L., Tosca, MA., Mosca, F., and Marseglia, GL.
- Published
- 2019
- Full Text
- View/download PDF
36. A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemia
- Author
-
Lin, Yulia, primary, Del Giudice, M. Elisabeth, additional, Kron, Amie, additional, Meirovich, Harley, additional, Sholzberg, Michelle, additional, Swarup, Vidushi, additional, Huang, Mary, additional, Distefano, Lanis, additional, Anani, Waseem Q., additional, Armali, Chantal, additional, Bussel, James B., additional, and Callum, Jeannie, additional
- Published
- 2023
- Full Text
- View/download PDF
37. A systematic review on drugs for synaptic plasticity in the treatment of dementia
- Author
-
Piscopo, P., primary, Crestini, A., additional, Carbone, E., additional, Rivabene, R., additional, Ancidoni, A., additional, Lo Giudice, M., additional, Corbo, M., additional, Vanacore, N., additional, and Lacorte, E., additional
- Published
- 2022
- Full Text
- View/download PDF
38. Knowledge management e intelligenza artificiale: rischi e opportunità per il management di impresa
- Author
-
DEL GIUDICE M., PAPA A., CAPUTO F., CILLO V., Pironti, M., DEL GIUDICE, M., Papa, A., Caputo, F., and Cillo, V.
- Published
- 2022
39. Diagnostic relevance of IgE sensitization profiles to eight recombinant Phleum pratense molecules
- Author
-
Cipriani, F., Mastrorilli, C., Tripodi, S., Ricci, G., Perna, S., Panetta, V., Asero, R., Dondi, A., Bianchi, A., Maiello, N., Miraglia del Giudice, M., Frediani, T., Macrì, F., Lucarelli, S., Dello Iacono, I., Patria, M. F., Varin, E., Peroni, D., Chini, L., Moschese, V., Bernardini, R., Pingitore, G., Pelosi, U., Tosca, M., Paravati, F., Sfika, I., Businco, A. Di Rienzo, Povesi Dascola, C., Comberiati, P., Frediani, S., Lambiase, C., Verga, M. C., Faggian, D., Plebani, M., Calvani, M., Caffarelli, C., and Matricardi, P. M.
- Published
- 2018
- Full Text
- View/download PDF
40. Biologic drugs in chronic spontaneous urticaria
- Author
-
Licari A., Manti S., Leonardi S., Minasi D., Caffarelli C., Cardinale F., Miraglia Del Giudice M., Calvani M., Ciprandi G., Marseglia G. L., Licari, A., Manti, S., Leonardi, S., Minasi, D., Caffarelli, C., Cardinale, F., Miraglia Del Giudice, M., Calvani, M., Ciprandi, G., and Marseglia, G. L.
- Subjects
Adult ,Male ,Biological Products ,Urticaria ,Chronic Disease ,Quality of Life ,Humans ,Chronic Urticaria ,Female ,Child - Abstract
Chronic spontaneous urticaria (CSU) is a condition defined by the presence of recurrent urticaria, angioedema, or both, which persist for more than six weeks in duration and occurs in the absence of an identifiable trigger. Both children and adults can develop CSU, although it is more common in adults and in women than in men, with a peak occurrence in the third to fifth decades of life. It imposes a significant burden on patients, families and healthcare systems. The goal of therapy in patients with CSU is to achieve a level of symptom control and improvement in quality of life that is acceptable to the patient, while minimizing therapy-related side effects. The recent introduction of biologic drugs has changed the management of the disease. This work aims to provide a narrative review of the current state of biological therapy and the promising drugs under development for CSU.
- Published
- 2021
41. Digital health in the management of allergic diseases
- Author
-
Pattini S., Pingitore G., Cardinale F., Licari A., Miraglia Del Giudice M., Calvani M., Chiappini E., Cravidi C., Marseglia G. L., Ricci G., Duse M., Tripodi S., Pattini, S., Pingitore, G., Cardinale, F., Licari, A., Miraglia Del Giudice, M., Calvani, M., Chiappini, E., Cravidi, C., Marseglia, G. L., Ricci, G., Duse, M., and Tripodi, S.
- Subjects
Immune-allergic patient ,Pandemic ,SARS-CoV-2 ,Hypersensitivity ,COVID-19 ,Humans ,App ,Pandemics ,Telemedicine ,Human - Abstract
In recent years there has been an important implementation in the medical field of both Mobile Health, such as the use of mobile communication devices, and of other telemedicine tools in general, with the aim of supporting the supervision of diseases from the moment of the first diagnosis to the therapeutic follow-up. In fact, Digital Health can also have a very positive impact on the management of allergic patients, who are known to have the greatest need for regular monitoring, simplifying contact between doctor and patient, but there is still a need to improve implementation regulations, define certification programs and adequate reimbursement systems, as well as to guarantee a high level of attention to the protection of sensitive data. The hope is that one positive outcome of the Covid-19 pandemic will be an acceleration, by all stake-holders involved, of the process of the modernization of health care. (www.actabiomedica.it).
- Published
- 2021
42. Hypersensitivity to polyethylene glycol in adults and children: An emerging challenge
- Author
-
Bianchi A., Bottau P., Calamelli E., Caimmi S., Crisafulli G., Franceschini F., Liotti L., Mori F., Paglialunga C., Saretta F., Tosca M., Cardinale F., Licari A., Miraglia Del Giudice M., Caffarelli C., Bianchi, A., Bottau, P., Calamelli, E., Caimmi, S., Crisafulli, G., Franceschini, F., Liotti, L., Mori, F., Paglialunga, C., Saretta, F., Tosca, M., Cardinale, F., Licari, A., Miraglia Del Giudice, M., and Caffarelli, C.
- Subjects
Adult ,COVID-19 Vaccines ,SARS-CoV-2 ,COVID-19 Vaccine ,technology, industry, and agriculture ,COVID-19 ,macromolecular substances ,PEG allergy ,Drug allergy ,Polyethylene Glycol ,Polyethylene Glycols ,Polyethylene glycol hypersensitivity ,Vaccine allergy ,Anaphylaxi ,Humans ,Child ,Anaphylaxis ,Human - Abstract
Hypersensitivity reactions to polyethylene glycol (PEG) is an emerging challenge and the interest about this disease is growing since PEG is considered one of the possible causes of coronavirus disease 2019 (COVID 19) vaccine-associated anaphylaxis. PEG is used in a wide variety of pharmaceutical, medical, in-dustrial, cosmetic, and food products and can be an active ingredient or used as an excipient. PEG is present in several medications, and it may or may not be present in different formulations and dosages of the same drug. Lack of standardization nomenclature, inadequate labelling of products and lack of knowledge about PEG involvement in hypersensitivity reactions expose patients at risk of presenting multiple reactions before a diagnosis could be made. In this review we describe the main cases published in literature and propose an allergy work-up and management. (www.actabiomedica.it).
- Published
- 2021
43. Update on Food protein-induced enterocolitis syndrome (FPIES)
- Author
-
Calvani M., Anania C., Bianchi A., D'Auria E., Cardinale F., Votto M., Martelli A., Tosca M., Chiappini E., Brambilla I., Miraglia Del Giudice M., Caffarelli C., Calvani, M., Anania, C., Bianchi, A., D'Auria, E., Cardinale, F., Votto, M., Martelli, A., Tosca, M., Chiappini, E., Brambilla, I., Miraglia Del Giudice, M., and Caffarelli, C.
- Subjects
Enterocolitis ,Humans ,Infant ,Syndrome ,Allergens ,Biomarkers ,Food Hypersensitivity - Abstract
Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE mediated food allergy (FA) characterized by delayed and severe gastrointestinal symptoms that typically occurs within the first year of life. Many aspects of this pathology are currently unclear. FPIES is classified as a non-IgE immune-mediated FA in which the immune response is thought to act mainly through cell-mediated mechanisms. In patients with FPIES, the symptom pattern is determined by the frequency and dose of food allergen in the diet. Diagnosis of FPIES may be difficult, mainly due to the lack of specific biomarkers to confirm or exclude the diagnosis. FPIES is a clinical diagnosis, mainly based on clinical features which, although not specific, are reproducible every time the patient takes the food. Different diagnostic criteria of FPIES were published over time in the literature. The present narrative review aims to analyze the current clinical evidence in epidemiology, pathophysiology, diagnosis, and management of this condition.
- Published
- 2021
44. LABAs in asthmatic children: Highlights and new inside
- Author
-
Miraglia del Giudice, M., Matera, M.G., Capristo, C., Conte, M., Santaniello, F., Chinellato, I., Leonardi, S., Miraglia del Giudice, M.C., and Perrone, L.
- Published
- 2013
- Full Text
- View/download PDF
45. Supply chain management in the era of circular economy: the moderating effect of big data
- Author
-
Del Giudice, M, Chierici, R, Mazzucchelli, A, Fiano, F, Del Giudice M., Chierici R., Mazzucchelli A., Fiano F., Del Giudice, M, Chierici, R, Mazzucchelli, A, Fiano, F, Del Giudice M., Chierici R., Mazzucchelli A., and Fiano F.
- Abstract
Purpose This paper analyzes the effect of circular economy practices on firm performance for a circular supply chain and explores the moderating role that big-data-driven supply chain plays within these relationships. Design/methodology/approach This study uses data collected through an online survey distributed to managers of 378 Italian firms that have adopted circular economy principles. The data are processed using multiple regression analysis. Findings The results indicate that the three categories of circular economy practices investigated – namely circular economy supply chain management design, circular economy supply chain relationship management and circular economy HR management – play a crucial role in enhancing firm performance from a circular economy perspective. A big-data-driven supply chain acts as a moderator of the relationship between circular economy HR management and firm performance for a circular economy supply chain. Originality/value This study makes a number of original contributions to research on circular economy practices in a big-data-driven supply chain and provides useful insights for practitioners. First, it answers the call to capture digital transformation trends and to extend research on sustainability in supply chain management. Second, it enhances the literature by investigating the relationships between three different kinds of circular economy supply chain practices and firm performance. Finally, it clarifies the moderating role of big data in making decisions and implementing circular supply chain solutions to achieve better environmental, social and economic benefits.
- Published
- 2020
46. Scientific Formulas and Cognitive Economics, beyond 'in Vitro' Entrepreneurship
- Author
-
Maggioni, V. and Del Giudice, M.
- Abstract
Cognitive economics is the fruit of intense "trans-epistemic" communication involving heterogeneous disciplinary areas: its most tangible application can be found in the dialogues between science and enterprise and in the relationship between cognition and entrepreneurship. The hypothesis of classical economics is that the academic inventor or corporate scientist operates under conditions of substantial rationality during the process of knowledge transfer from research to enterprise. The reality, however, is that their actions owe much to spontaneity and unpredictability, deriving from their personal knowledge set and from the opportunities for dynamic learning and for relationships with other individuals offered by laboratory life. The cognitive matrix of academic spin-offs is therefore complex and, if there is to be effective connection with people and innovative organizations capable of enhancing their prospects of success, the old vision that is confined to one-dimensional aspects of the entrepreneurial phenomenon must be rejected. There is thus a need for an integrated study which simultaneously takes into account the particular context, the business model and the individual mechanisms of sharing and transferring knowledge. (Contains 1 figure.)
- Published
- 2008
47. Prognostic factors for survival in patients with lung metastases from gynaecological tract cancers
- Author
-
Chiappetta, M., Gallotta, Valerio, Pogliani, L., Zanfrini, E., Fagotti, Anna, Ferrandina, Maria Gabriella, Fanfani, Francesco, Nachira, Dania, Meacci, Elisa, Congedo, Maria Teresa, Lococo, Filippo, Giudice, M. T., Scambia, Giovanni, Margaritora, Stefano, Gallotta V., Fagotti A. (ORCID:0000-0001-5579-335X), Ferrandina G. (ORCID:0000-0003-4672-4197), Fanfani F. (ORCID:0000-0003-1991-7284), Nachira D. (ORCID:0000-0003-2937-9678), Meacci E. (ORCID:0000-0001-8424-3816), Congedo M. T., Lococo F. (ORCID:0000-0002-9383-5554), Scambia G. (ORCID:0000-0003-2758-1063), Margaritora S. (ORCID:0000-0002-9796-760X), Chiappetta, M., Gallotta, Valerio, Pogliani, L., Zanfrini, E., Fagotti, Anna, Ferrandina, Maria Gabriella, Fanfani, Francesco, Nachira, Dania, Meacci, Elisa, Congedo, Maria Teresa, Lococo, Filippo, Giudice, M. T., Scambia, Giovanni, Margaritora, Stefano, Gallotta V., Fagotti A. (ORCID:0000-0001-5579-335X), Ferrandina G. (ORCID:0000-0003-4672-4197), Fanfani F. (ORCID:0000-0003-1991-7284), Nachira D. (ORCID:0000-0003-2937-9678), Meacci E. (ORCID:0000-0001-8424-3816), Congedo M. T., Lococo F. (ORCID:0000-0002-9383-5554), Scambia G. (ORCID:0000-0003-2758-1063), and Margaritora S. (ORCID:0000-0002-9796-760X)
- Abstract
OBJECTIVES: Lung metastases from gynaecological tract cancers are rare, and prognostic factors are still undefined. The goal of this study was to analyse prognostic factors for survival in this group of patients. METHODS: Data of patients with lung metastases from gynaecological tract cancers who underwent surgical resections from 1 January 2005 to 31 May 2019 were reviewed retrospectively. All patients were treated surgically if the primitive tumour was under control and the lung was the only organ involved. Clinical and pathological data associated with metastatic patterns and previous treatment types were correlated with overall survival (OS) and disease-free survival using Kaplan-Meier curves, whereas the log-rank test was used to assess differences between subgroups. RESULTS: The analysis was conducted on 55 patients. OS was 65% at 5 years. With univariable analysis, age >45 years (P = 0.022) and the absence of pleural infiltration (P = 0.001) were determined to be favourable prognostic factors. The 5-year OS was 69.9% versus 53.3% in patients with pleural involvement. Multivariable analysis confirmed the absence of pleural infiltration as a favourable independent prognostic factor; the hazard ratio was 0.06; the 95% confidence interval was 0.00-0.23 (P = 0.011).At univariable analysis, the absence of pleural infiltration was determined to be a favourable prognostic factor (P = 0.034) for disease-free survival. The numbers and dimensions of the metastases did not influence survival in these patients.In uterine cancers of endometrial or cervical origin, the presence of pleural infiltration (P = 0.001), lymph node involvement (P = 0.001) and young age (P = 0.044) were considered unfavourable prognostic factors for OS. CONCLUSIONS: Surgical treatment in technically resectable gynaecological tract metastases may represent an important option. Pleural infiltration and lymph node metastases seem to be adverse prognostic factors.
- Published
- 2022
48. Update on the Management of Pediatric Psoriasis: An Italian Consensus
- Author
-
Peris, Ketty, Fortina, A. B., Bianchi, L., Fabbrocini, G., Gisondi, P., Balato, A., Bardazzi, F., Bernardini, N., Bonamonte, D., Bongiorno, M. R., Buligan, C., Cusano, F., Del Giudice, M. B. D. F., Hachem, M. E., Fargnoli, Maria Concetta, Gualdi, G., Guarneri, C., Hansel, K., Malara, G., Mazzatenta, C., Micali, G., Narcisi, A., Neri, I., Oranges, T., Panzone, M., Parodi, A., Restano, L., Simonetti, O., Venturini, M., Di Lernia, V., Peris K. (ORCID:0000-0002-5237-0463), Fargnoli M. C., Peris, Ketty, Fortina, A. B., Bianchi, L., Fabbrocini, G., Gisondi, P., Balato, A., Bardazzi, F., Bernardini, N., Bonamonte, D., Bongiorno, M. R., Buligan, C., Cusano, F., Del Giudice, M. B. D. F., Hachem, M. E., Fargnoli, Maria Concetta, Gualdi, G., Guarneri, C., Hansel, K., Malara, G., Mazzatenta, C., Micali, G., Narcisi, A., Neri, I., Oranges, T., Panzone, M., Parodi, A., Restano, L., Simonetti, O., Venturini, M., Di Lernia, V., Peris K. (ORCID:0000-0002-5237-0463), and Fargnoli M. C.
- Abstract
Introduction: Psoriasis affects children with a considerable burden in early life. Treating pediatric psoriasis is challenging also because of the lack of updated specific guidelines. With the recent approval of several biologics for pediatric psoriasis and the ongoing COVID-19 pandemic, the management of young psoriatic patients is facing major changes. A revision of treatment recommendations is therefore needed. Methods: In September 2021, a board of six Italian dermatologists convened to update treatment recommendations. The board issued evidence- and consensus-based statements covering relevant areas of pediatric psoriasis, namely: assessment of psoriasis severity, management of children with psoriasis, and treatment of pediatric psoriasis. To reach consensus, the statements were submitted to a panel of 24 experts in a Delphi process performed entirely via videoconference. A treatment algorithm was produced. Results: There was full consensus that psoriasis severity is determined by the extension/severity of skin lesions, site of lesions, and impact on patient quality of life. Agreement was reached on the need for a multidisciplinary approach to pediatric psoriasis and the importance of patient/parents education. The relevance of vaccinations, including COVID-19 vaccination, for psoriatic children was acknowledged by all participants. Management issues that initially failed to reach consensus included the screening for psoriasis comorbidities and early treatment with biologics to prevent them and the use of telemedicine to facilitate patient follow-up. There was full consensus that topical corticosteroids are the first choice for the treatment of mild pediatric psoriasis, while phototherapy and systemic therapy are used in children with moderate-severe psoriasis. According to the proposed treatment algorithm, biologics are the first line of systemic therapy. Conclusions: Targeted systemic therapies are changing the treatment of moderate-severe pediatric psoriasis
- Published
- 2022
49. Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer
- Author
-
Moruzzi, M. C., Bolomini, G., Esposito, R., Mascilini, F., Ciccarone, Francesca, Quagliozzi, L., Giudice, M. T., Beneduce, Giuliana, Ficarelli, S., Moroni, R., Scambia, Giovanni, Fagotti, Anna, Testa, Antonia Carla, Moro, Francesca, Ciccarone F., Beneduce G., Scambia G. (ORCID:0000-0003-2758-1063), Fagotti A. (ORCID:0000-0001-5579-335X), Testa A. C. (ORCID:0000-0003-2217-8726), Moro F., Moruzzi, M. C., Bolomini, G., Esposito, R., Mascilini, F., Ciccarone, Francesca, Quagliozzi, L., Giudice, M. T., Beneduce, Giuliana, Ficarelli, S., Moroni, R., Scambia, Giovanni, Fagotti, Anna, Testa, Antonia Carla, Moro, Francesca, Ciccarone F., Beneduce G., Scambia G. (ORCID:0000-0003-2758-1063), Fagotti A. (ORCID:0000-0001-5579-335X), Testa A. C. (ORCID:0000-0003-2217-8726), and Moro F.
- Abstract
Background: Surgical exploration remains the gold standard for evaluating the extension of disease and predicting resectability. A laparoscopy-based scoring model was developed by Fagotti and colleagues in 2006 and updated in 2015, based on the intraoperative presence or absence of some specific cancer features. The model proved an overall accuracy rate of 77% to 100% and is considered the reference test for assessing resectability in our institution. Objective: The primary aim of the study was to analyze the agreement between preoperative ultrasound examination and laparoscopic findings in assessing the extension of intraabdominal disease using 6 parameters described by Fagotti's score. Study Design: This was a prospective single-center observational study. Between January 2019 and June 2020, consecutive patients with clinical or radiological suspicion of ovarian or peritoneal cancer were assessed with preoperative ultrasound examination and assigned a score based on the 6 Fagotti score parameters (great omentum, liver surface, lesser omentum/stomach/spleen, parietal peritoneum, diaphragms, bowel disease). Presence of mesenteral retraction of the small bowel and miliary carcinomatosis on the serosa were also evaluated. Each parameter was correlated with laparoscopic findings. Concordance was calculated between ultrasound and laparoscopic parameters using Cohen's kappa. Results: Cohen's kappa ranged from 0.70 to 0.90 for carcinomatosis on the small or large bowel, supracolic omentum, liver surface, and diaphragms. Cohen's kappa test was lower for carcinomatosis on the parietal peritoneum (k=0.63) and on the lesser omentum or lesser curvature of the stomach or spleen (k=0.54). The agreement between ultrasound and surgical predictive index value (score) was k=0.74. For the evaluation of mesenteral retraction and miliary carcinomatosis, the agreement was low (k=0.57 and k=0.36, respectively). Conclusion: The results of ultrasound and laparoscopy in the assessment of in
- Published
- 2022
50. Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer
- Author
-
Nero, Camilla, Boldrini, Luca, Lenkowicz, Jacopo, Giudice, M. T., Piermattei, Angelo, Inzani, Frediano, Pasciuto, Tina, Minucci, Angelo, Fagotti, Anna, Zannoni, Gian Franco, Valentini, Vincenzo, Scambia, Giovanni, Nero C., Boldrini L., Lenkowicz J., Piermattei A. (ORCID:0000-0002-6835-1179), Inzani F., Pasciuto T. (ORCID:0000-0003-2959-8571), Minucci A., Fagotti A. (ORCID:0000-0001-5579-335X), Zannoni G. (ORCID:0000-0003-1809-129X), Valentini V. (ORCID:0000-0003-4637-6487), Scambia G. (ORCID:0000-0003-2758-1063), Nero, Camilla, Boldrini, Luca, Lenkowicz, Jacopo, Giudice, M. T., Piermattei, Angelo, Inzani, Frediano, Pasciuto, Tina, Minucci, Angelo, Fagotti, Anna, Zannoni, Gian Franco, Valentini, Vincenzo, Scambia, Giovanni, Nero C., Boldrini L., Lenkowicz J., Piermattei A. (ORCID:0000-0002-6835-1179), Inzani F., Pasciuto T. (ORCID:0000-0003-2959-8571), Minucci A., Fagotti A. (ORCID:0000-0001-5579-335X), Zannoni G. (ORCID:0000-0003-1809-129X), Valentini V. (ORCID:0000-0003-4637-6487), and Scambia G. (ORCID:0000-0003-2758-1063)
- Abstract
BRCA 1/2 genes mutation status can already determine the therapeutic algorithm of high grade serous ovarian cancer patients. Nevertheless, its assessment is not sufficient to identify all patients with genomic instability, since BRCA 1/2 mutations are only the most well-known mechanisms of homologous recombination deficiency (HR-d) pathway, and patients displaying HR-d behave similarly to BRCA mutated patients. HRd assessment can be challenging and is progressively overcoming BRCA testing not only for prognostic information but more importantly for drugs prescriptions. However, HR testing is not already integrated in clinical practice, it is quite expensive and it is not refundable in many countries. Selecting patients who are more likely to benefit from this assessment (BRCA 1/2 WT patients) at an early stage of the diagnostic process, would allow an optimization of genomic profiling resources. In this study, we sought to explore whether somatic BRCA1/2 genes status can be predicted using computational pathology from standard hematoxylin and eosin histology. In detail, we adopted a publicly available, deep-learning-based weakly supervised method that uses attention-based learning to automatically identify sub regions of high diagnostic value to accurately classify the whole slide (CLAM). The same model was also tested for progression free survival (PFS) prediction. The model was tested on a cohort of 664 (training set: n = 464, testing set: n = 132) ovarian cancer patients, of whom 233 (35.1%) had a somatic BRCA 1/2 mutation. An area under the curve of 0.7 and 0.55 was achieved in the training and testing set respectively. The model was then further refined by manually identifying areas of interest in half of the cases. 198 images were used for training (126/72) and 87 images for validation (55/32). The model reached a zero classification error on the training set, but the performance was 0.59 in terms of validation ROC AUC, with a 0.57 validation accuracy. Finally
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.